Editas Medicine (EDIT) Net Margin Growth (5y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34,541.00 |
| Jun 30, 2025 | -121,941.00 |
| Mar 31, 2025 | -96,520.00 |
| Dec 31, 2024 | 15,915.00 |
| Sep 30, 2024 | -10.10 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | -404,500.00 |
| Dec 31, 2023 | 37,804.00 |
| Sep 30, 2023 | -73,873.00 |
| Jun 30, 2023 | -87,005.00 |
| Mar 31, 2023 | 30,616.00 |
| Dec 31, 2022 | 5,766.00 |
| Sep 30, 2022 | -13.23 Mn |
| Jun 30, 2022 | 981.00 |
| Mar 31, 2022 | 381,708.00 |
| Dec 31, 2021 | 405,255.00 |
| Sep 30, 2021 | 155,406.00 |
| Jun 30, 2021 | -1.40 Mn |
| Mar 31, 2021 | 133,699.00 |
| Dec 31, 2020 | 106,025.00 |
| Sep 30, 2020 | 113,319.00 |
| Jun 30, 2020 | 2.83 Mn |